Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

Ali Nokhodchi; El Larhrib

doi:10.4155/tde.13.64

Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

Ali Nokhodchi, El Larhrib

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier

Original language	English
Pages (from-to)	879-882
Number of pages	4
Journal	Therapeutic Delivery
Volume	4
Issue number	8
DOIs	https://doi.org/10.4155/tde.13.64
Publication status	Published - 2013

Access to Document

10.4155/tde.13.64Licence: Other

Cite this

@article{6564b090dacd4e9db2c4363bc3832658,

title = "Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles",

abstract = "Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier",

keywords = "aerosolization performance, dry-powder inhaler, lactose, mannitol, particle engineering",

author = "Ali Nokhodchi and El Larhrib",

year = "2013",

doi = "10.4155/tde.13.64",

language = "English",

volume = "4",

pages = "879--882",

journal = "Therapeutic Delivery",

issn = "2041-5990",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

AU - Nokhodchi, Ali

AU - Larhrib, El

PY - 2013

Y1 - 2013

N2 - Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier

AB - Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier

KW - aerosolization performance

KW - dry-powder inhaler

KW - lactose

KW - mannitol

KW - particle engineering

U2 - 10.4155/tde.13.64

DO - 10.4155/tde.13.64

M3 - Article

SN - 2041-5990

VL - 4

SP - 879

EP - 882

JO - Therapeutic Delivery

JF - Therapeutic Delivery

IS - 8

ER -

Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

Abstract

Access to Document

Fingerprint

Cite this